{
    "nct_id": "NCT03378128",
    "official_title": "Minimally Invasive Interval Debulking Surgery in Ovarian Cancer",
    "inclusion_criteria": "* Subjects must have histologically or cytologically confirmed advanced epithelial ovarian, fallopian tube, or primary peritoneal (â‰¥ International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC)\n* Subjects must have received neoadjuvant chemotherapy (any number of cycles) with complete or partial response as assessed by Response Evaluation Criteria in Solid Tumors 1.1 (RECIST) or CA 125 response by Gynecologic Cancer Intergroup (GCIG) criteria\n* Performance status Eastern Cooperative Oncology Group (ECOG) performance status 0-2\n* Subjects must have the ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 19 Years",
    "exclusion_criteria": "* Severe cardiopulmonary disease precluding the use of the minimally invasive technique as deemed by Internal Medicine Preoperative Assessment, Consultant and Treatment (IMPACT)\n* Inability to tolerate prolonged Trendelenburg position as deemed by anesthesiology\n* Severe hip disease precluding the use of dorsolithotomy position\n* Prior pelvic or abdominal radiation\n* Clinically large pelvic masses reaching above the umbilicus\n* Absence of a documented PR or CR according to RECIST 1.1 or CA 125 response by GCIG criteria to neoadjuvant chemotherapy\n* Presence of parenchymal liver metastases on imaging\n* Absence of baseline imaging studies (CT abdomen/pelvis and Chest x-ray minimum) both prior to beginning chemotherapy and following chemotherapy",
    "miscellaneous_criteria": ""
}